Molecular alterations in pancreatic tumors

Michela Visani1, Giorgia Acquaviva1, Antonio De Leo1

  • 1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna-Molecular Diagnostic Unit, Azienda USL di Bologna, Bologna 40138, Italy.

Insights

Genetic alterations in pancreatic tumors involve oncogenes, tumor suppressors, and DNA repair genes. Molecular testing, including next-generation sequencing, aids in diagnosing pancreatic lesions and characterizing specific tumor types.

Area of Science:

  • Oncology
  • Genetics
  • Gastroenterology

Background:

  • Pancreatic tumors exhibit genetic alterations including oncogene activation, tumor suppressor gene inactivation, and DNA repair gene dysfunction.
  • Endoscopic ultrasound-guided fine-needle aspiration improves diagnosis but challenges remain for inconclusive specimens.
  • Molecular testing offers potential solutions for ambiguous pancreatic lesion diagnoses.

Purpose of the Study:

  • To review the primary molecular alterations identified in various pancreatic tumors.
  • To highlight the utility of multi-gene analysis in characterizing pancreatic neoplasms.

Main Methods:

  • Literature review summarizing key findings on genetic alterations in pancreatic tumors.
  • Discussion of next-generation sequencing as a tool for molecular characterization.

Main Results:

  • Pancreatic tumors are characterized by specific genetic profiles.
  • Distinct molecular alterations define different pancreatic tumor types, such as pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms.

Conclusions:

  • Understanding molecular alterations is crucial for diagnosing and managing pancreatic tumors.
  • Advanced molecular techniques like next-generation sequencing enhance the characterization of pancreatic neoplasms.